ISPOR - PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase- Five-Years Follow-up Simulated Cohort

Full Text

PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase- Five-Years Follow-up Simulated Cohort

Abstract

Authors

J. Darba N. Perez-Alvarez L. Kaskens P. Martin

Back to Volume 14, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now